Home / Auditor changes / Emmaus Life Sciences, Inc.
Filed 2025-05-06 路 Form 8-K 路 Accession 0001213900-25-039783 nano
Price before filing: $0.0165 (2025-05-05 close, split/dividend-adjusted)
Market cap at flag: $830,252 (2025-05-06) 路 Latest: $4.1M (2026-10-16)
| Window | EMMA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -4.1% | +5.2% | -9.4% | 2025-06-05 |
| 90 days | -3.0% | +12.3% | -15.4% | 2025-08-04 |
| 180 days | -33.3% | +22.0% | -55.3% | 2025-11-03 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"On November 1, 2024, CBIZ CPAs P.C. ("CBIZ CPAs") acquired the attest business of Marcum LLP ("Marcum"), Accordingly, on May 2, 2025, as a result of the acquisition, Marcum resigned as the independent registered public accounting firm of Emmaus Life Sciences, Inc."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: resigned
Disagreements reported: no
Why this score: auditor resigned; also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.